These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. Pertwee RG; Stevenson LA; Griffin G Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes. Shivachar AC Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778 [TBL] [Abstract][Full Text] [Related]
8. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755 [TBL] [Abstract][Full Text] [Related]
9. Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats. Morera-Herreras T; Ruiz-Ortega JA; Linazasoro G; Ugedo L Psychopharmacology (Berl); 2011 Mar; 214(2):379-89. PubMed ID: 20959968 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation. Makwana R; Molleman A; Parsons ME Br J Pharmacol; 2010 Apr; 159(8):1608-22. PubMed ID: 20233228 [TBL] [Abstract][Full Text] [Related]
11. Anandamide and WIN 55212-2 Afford Protection in Rat Brain Mitochondria in a Toxic Model Induced by 3-Nitropropionic Acid: an In Vitro Study. Maya-López M; Monsalvo-Maraver LA; Delgado-Arzate AL; Olivera-Pérez CI; El-Hafidi M; Silva-Palacios A; Medina-Campos O; Pedraza-Chaverri J; Aschner M; Tinkov AA; Túnez I; Retana-Márquez S; Zazueta C; Santamaría A Mol Neurobiol; 2024 Sep; 61(9):6435-6452. PubMed ID: 38307967 [TBL] [Abstract][Full Text] [Related]
12. Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes. Bloom AS; Edgemond WS; Moldvan JC Neurochem Res; 1997 May; 22(5):563-8. PubMed ID: 9131634 [TBL] [Abstract][Full Text] [Related]
13. Do cannabinoids exhibit a tyramine-like effect? Ilayan E; Feliszek M; Malinowska B; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1041-6. PubMed ID: 23900610 [TBL] [Abstract][Full Text] [Related]
14. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed. Pakdeechote P; Dunn WR; Ralevic V Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668 [TBL] [Abstract][Full Text] [Related]
15. Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice. Raffa RB; Stone DJ; Hipp SJ Neurosci Lett; 1999 Mar; 263(1):29-32. PubMed ID: 10218903 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. Sun Y; Alexander SP; Garle MJ; Gibson CL; Hewitt K; Murphy SP; Kendall DA; Bennett AJ Br J Pharmacol; 2007 Nov; 152(5):734-43. PubMed ID: 17906680 [TBL] [Abstract][Full Text] [Related]